| __timestamp | ACADIA Pharmaceuticals Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 8901000 |
| Thursday, January 1, 2015 | 76369000 | 9574000 |
| Friday, January 1, 2016 | 4406000 | 14695000 |
| Sunday, January 1, 2017 | 13060000 | 8437000 |
| Monday, January 1, 2018 | 18330000 | 12723000 |
| Tuesday, January 1, 2019 | 19598000 | 51272000 |
| Wednesday, January 1, 2020 | 20550000 | 50052000 |
| Friday, January 1, 2021 | 19141000 | 783000 |
| Saturday, January 1, 2022 | 10166000 | 868000 |
| Sunday, January 1, 2023 | 45731000 | 123740000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for ACADIA Pharmaceuticals Inc. and Geron Corporation from 2014 to 2023. Over this period, ACADIA Pharmaceuticals experienced a significant fluctuation, with costs peaking in 2015 and 2023, showing a 25% increase from 2014 to 2023. In contrast, Geron Corporation's cost of revenue surged dramatically by over 1,300% from 2014 to 2023, highlighting a strategic shift or increased operational scale.
The data reveals that while ACADIA's costs remained relatively stable, Geron faced more volatility, particularly in 2019 and 2023. These insights provide a window into each company's operational strategies and market positioning, offering valuable information for potential investors and industry analysts.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: GSK plc vs Geron Corporation
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.